Breast Lift Surgery: Procedure, Cost, Recovery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Mastopexy (breast lift) is a surgical procedure that raises and reshapes ptotic (sagging) breasts by removing excess skin, tightening the surrounding tissue, and repositioning the nipple-areola complex to a higher, more youthful position. Unlike breast augmentation, mastopexy does not significantly change breast volume — it corrects the position and shape of existing breast tissue. When volume loss accompanies ptosis (as commonly occurs after pregnancy or weight loss), augmentation may be performed concurrently or staged.

Breast ptosis is classified by the position of the nipple relative to the inframammary fold (the crease under the breast). Grade I (mild) ptosis: nipple at or within 1cm below the fold. Grade II (moderate): nipple 1-3cm below the fold. Grade III (severe): nipple more than 3cm below the fold, often pointing downward. Pseudoptosis (glandular ptosis) refers to the breast tissue dropping below the fold while the nipple remains above it — this is a distinct condition affecting technique selection. The degree of ptosis determines which mastopexy technique is most appropriate.

Mastopexy is performed under general anaesthesia and takes 2-3 hours. The nipple-areola complex is elevated on a pedicle of breast tissue that maintains its blood and nerve supply. Excess skin is removed from the lower and outer breast, the remaining breast tissue is reshaped and supported, and the skin is redraped over the new contour. The technique is determined by the amount of lift required and the surgeon's training and preference.

Post-partum women and women who have experienced significant weight loss represent the most common patient groups seeking mastopexy, as the skin stretch from these changes creates ptosis that does not self-correct with further weight management or exercise. Mastopexy is considered one of the more complex breast procedures, requiring artistic judgment in addition to surgical technical skill to achieve symmetric, natural-appearing results.

Mastopexy primarily addresses breast ptosis — sagging caused by the stretching and loss of elasticity of the breast skin envelope following pregnancy and breastfeeding (the most common cause), significant weight fluctuation, ageing, gravitational effects on larger breasts, or post-augmentation implant removal. Patients present with breasts that appear deflated, elongated, with nipples pointing downward, and with the nipple position at or below the inframammary fold.

Mastopexy also corrects areola enlargement (macroaereola) that commonly accompanies ptosis — the periareolar suture used in lift techniques simultaneously reduces areola diameter. Asymmetric ptosis (one breast more ptotic than the other) is corrected by applying different degrees of lift bilaterally. The procedure is a component of 'mummy makeover' combined procedures addressing multiple post-pregnancy body changes simultaneously. Mastopexy at the time of implant removal allows restoration of breast shape for patients who choose to remove their implants, compensating for the tissue descent that occurs with explantation.

Good mastopexy candidates are women with Grade II or Grade III ptosis at stable weight who have completed their families (or accept that future pregnancies may require revision), are non-smokers, and in good general health. Smokers carry a substantially elevated risk of nipple-areola complex necrosis due to impaired microcirculation — most surgeons require cessation 6 weeks before and 6 weeks after surgery as a minimum. Patients with adequate breast volume but sagging skin who prefer not to have implants are ideal candidates for mastopexy alone.

Relative contraindications include obesity (elevated wound complication risk), poorly controlled diabetes, immunosuppression, anticoagulant therapy, and keloid-prone skin (mastopexy creates significant scars that may hypertrophy in susceptible patients). Patients with Grade I (mild) ptosis may not require a full lift — smaller scar options or augmentation alone with a very well-chosen implant pocket position may achieve sufficient improvement. The treating plastic surgeon will assess ptosis grade, breast volume, skin quality, and nipple position to recommend the most appropriate technique and discuss the trade-off between correction achieved and scar length.

Mastopexy techniques are named by their incision pattern, which determines both the degree of correction achievable and the extent of visible scarring. The Benelli or periareolar (donut) lift places the scar exclusively around the areola, achievable only for mild ptosis Grade I or pseudoptosis — it produces the least visible scarring but the least correction and can cause areola spreading and puckering. The vertical (lollipop) lift adds a vertical scar from the bottom of the areola to the inframammary fold, allowing moderate ptosis correction with better shape than the periareolar technique alone; scarring is limited to the vertical and areolar components.

The Wise pattern (anchor or inverted T) mastopexy adds a horizontal scar along the inframammary fold to the vertical pattern, enabling the most correction for severe ptosis. This is the most commonly performed technique for significant ptosis and provides the greatest improvement in breast shape and position, but creates the most extensive scarring — a 'keyhole' pattern of scars around the areola, down the front of the breast, and along the crease. The Hall-Findlay vertical mastopexy is a widely adopted evolution that avoids the horizontal scar for moderate ptosis patients while providing excellent shape. Combined augmentation mastopexy adds an implant to a mastopexy of any type — this is significantly more complex and requires careful planning of tissue blood supply.

Mastopexy produces a dramatically more youthful, elevated breast position with improved projection and shape. The nipple-areola complex is repositioned to a natural height on the breast mound, eliminating the downward-pointing, deflated appearance of ptotic breasts. Patient satisfaction rates are high — validated BREAST-Q data demonstrate significant improvements in breast satisfaction, psychosocial wellbeing, and sexual wellbeing scores maintained at 3 and 5 years post-operatively.

Functional benefits include resolution of skin fold rash and irritation under the breast (inframammary intertrigo), improved ability to wear fitted clothing and swimwear without specialist bra support, and relief from bra strap grooving discomfort associated with very ptotic heavy breasts. For women who have experienced significant breast changes after multiple pregnancies, mastopexy is frequently described as one of the most personally meaningful cosmetic procedures, restoring a pre-pregnancy body image that exercise alone cannot achieve.

The most significant risk specific to mastopexy is compromise of the blood supply to the nipple-areola complex (NAC), which is elevated on a pedicle of breast tissue. Partial or complete NAC necrosis — while uncommon in well-selected patients with an experienced surgeon — is a serious complication that may result in NAC loss. Risk factors include smoking, very long pedicle length (in large-volume corrections), prior breast surgery or radiation, diabetes, and obesity. Surgeons assess NAC blood supply intraoperatively and may temporarily delay skin closure if ischaemia is apparent.

Wound dehiscence at the T-junction (where the vertical and horizontal scars meet) is a common minor complication occurring in 5-15% of anchor mastopexy cases — it is usually managed conservatively with wound care over several weeks. Asymmetry requiring revision affects 10-15% of patients. Scars from mastopexy are unavoidable and extensive; while they typically fade significantly over 12-18 months, some patients develop hypertrophic (thickened) or widened scars, particularly at the inframammary component. Altered nipple sensation — numbness or hypersensitivity — is very common immediately post-operatively and resolves in the majority of patients within 3-12 months. Loss of ability to breastfeed is a concern for women who have not yet completed their families.

Mastopexy patients are typically discharged on the day of surgery or the following morning. A supportive surgical bra without underwire is worn continuously for 4-6 weeks. Bruising and swelling peak at 48-72 hours and largely resolve within 3-4 weeks. Wound dressings are changed at 5-7 days; sutures (if non-absorbable) are removed at 10-14 days. Return to desk work is typical at 10-14 days; strenuous arm activity and chest exercises are restricted for 6-8 weeks.

Scar management begins once sutures are removed or wounds are healed — silicone strips, gel sheets, or silicone scar gel are applied daily for 3-6 months. Scar massage with moisturising oil (vitamin E, rosehip) is commenced at 6 weeks. Sun protection is critical for scars in the first 12 months as UV exposure causes permanent pigmentation. Final breast shape — accounting for residual swelling and skin settling — is assessed at 6-12 months. Patients who subsequently become pregnant are counselled that the changes of pregnancy may require revision mastopexy after completing their family.

Mastopexy in the USA costs USD 8,000-14,000 (surgeon, anaesthesia, facility) for a standard vertical or anchor technique. Combined augmentation mastopexy adds implant costs and surgical complexity, typically USD 10,000-18,000 in the USA and GBP 8,000-14,000 in the UK. Minor periareolar lift costs less (USD 5,000-8,000) due to shorter operative time. Revision mastopexy carries similar costs to primary procedures.

Medical tourism for breast lift surgery offers significant cost reductions. Turkey: USD 3,500-6,000 for standard mastopexy; USD 5,000-9,000 combined with augmentation. India: USD 2,000-4,000 for mastopexy alone. Thailand: USD 4,500-7,000. Poland and Czech Republic: USD 3,000-5,500 for European medical tourists. Travel and accommodation (minimum 7-10 days for safe recovery before flying) add USD 1,500-3,000 to the total cost. Total savings of 40-65% versus US or UK prices are achievable at JCI-accredited facilities. MyMedicPlus can connect patients with board-certified plastic surgeons at vetted centres.

Non-surgical breast lifting technologies — radiofrequency (Thermage, Morpheus8), HIFU (Ultherapy), and thread lifts — provide modest improvement in mild skin laxity and early ptosis but cannot correct Grade II or Grade III ptosis. These are appropriate for patients with very early changes who are not ready for surgery, or those seeking maintenance between surgical procedures. Thread lift for the breast using barbed absorbable sutures (Silhouette Soft or similar) provides temporary (12-18 months) lifting of mild ptosis — considerably less correction than surgical mastopexy and with a different risk profile.

Breast augmentation alone (without mastopexy) can appear to lift mildly ptotic breasts by filling the skin envelope — this is appropriate only for Grade I ptosis or pseudoptosis where the nipple remains above the fold; in true ptosis, augmentation without mastopexy creates a 'waterfall' or 'Snoopy' deformity with the implant visible above the breast tissue. The definitive treatment for significant breast ptosis is surgical mastopexy, which is the only reliable method for repositioning the nipple-areola complex and reshaping the breast mound.